Back
uniQure NV Vs. Pharming Group Industry Stock Comparison
Sell
23
QURE
uniQure NV
Last Price:
5.78
Seasonality Move:
10.46%
Sell
42
PHAR
Pharming Group
Last Price:
7.48
Seasonality Move:
13.41%
Sell
23
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
- The current uniQure NV [QURE] share price is $5.85. The Score for QURE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- QURE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $7.76. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $5.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing buying pressure, which is a positive indicator for future bullish movement.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $7.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.
QURE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 43.86 | Sell |
Chaikin Money Flow: | 435453 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.89 - 7.05) | Sell |
Bollinger Bands (100): | (5.16 - 7.62) | Sell |
PHAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 42.78 | Sell |
Chaikin Money Flow: | 10574 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.88 - 8.8) | Sell |
Bollinger Bands (100): | (7.59 - 8.61) | Sell |
QURE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.25 | Sell |
20-day SMA: | 6.46 | Sell |
50-day SMA: | 5.92 | Sell |
200-day SMA: | 5.75 | Buy |
8-day EMA: | 6.17 | Sell |
20-day EMA: | 6.32 | Sell |
50-day EMA: | 6.18 | Sell |
200-day EMA: | 6.48 | Sell |
PHAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.86 | Sell |
20-day SMA: | 8.21 | Sell |
50-day SMA: | 8.25 | Sell |
200-day SMA: | 9.11 | Sell |
8-day EMA: | 7.85 | Sell |
20-day EMA: | 8.09 | Sell |
50-day EMA: | 8.19 | Sell |
200-day EMA: | 9.02 | Sell |
uniQure NV Earnings Growth & QURE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.34 per share, and an increase next year of $0.99 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
uniQure NV Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pharming Group Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |